| 000 | 01827 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250517110146.0 | ||
| 264 | 0 | _c20180206 | |
| 008 | 201802s 0 0 eng d | ||
| 022 | _a1745-6215 | ||
| 024 | 7 |
_a10.1186/s13063-016-1481-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLiu, Wei | |
| 245 | 0 | 0 |
_aA multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of Tong Luo Hua Shi capsule, a modernized Tibetan medicine, in patients with rheumatoid arthritis. _h[electronic resource] |
| 260 |
_bTrials _c07 2016 |
||
| 300 |
_a359 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xblood |
| 650 | 0 | 4 | _aCapsules |
| 650 | 0 | 4 | _aChina |
| 650 | 0 | 4 | _aDisability Evaluation |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aDrugs, Chinese Herbal _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPain Measurement |
| 650 | 0 | 4 | _aRecovery of Function |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aWu, Yuan-Hao | |
| 700 | 1 | _aHu, Si-Yuan | |
| 700 | 1 | _aZhong, Cheng-Liang | |
| 700 | 1 | _aGao, Ming-Li | |
| 700 | 1 | _aLiu, Dong-Wu | |
| 700 | 1 | _aWang, Hai-Yun | |
| 700 | 1 | _aChen, Mu-Zhi | |
| 700 | 1 | _aSong, Yue-Jin | |
| 700 | 1 | _aYang, Ben-Zha-Xi | |
| 700 | 1 | _aZheng, Qing-Shan | |
| 700 | 1 | _aYao, Hua | |
| 700 | 1 | _aQi, Xue-Bing | |
| 700 | 1 | _aLi, Gang | |
| 773 | 0 |
_tTrials _gvol. 17 _gp. 359 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s13063-016-1481-3 _zAvailable from publisher's website |
| 999 |
_c26273029 _d26273029 |
||